Skip to main content

Melatonin deficiency decreases brown adipose tissue acute thermogenic capacity of in rats measured by 18F-FDG PET

Abstract

Objective

Melatonin has been shown to increase brown adipose tissue (BAT) mass, which can lead to important metabolic effects, such as bodyweight reduction and glycemic improvement. However, BAT mass can only be measured invasively and. The gold standard for non-invasive measurement of BAT activity is positron emission tomography with 2-deoxy-2-[fluorine-18] fluoro-d-glucose (18F-FDG PET). There is no study, to our knowledge, that has evaluated if melatonin influences BAT activity, measured by this imaging technique in animals.

Methods

Three experimental groups of Wistar rats (control, pinealectomy, and pinealectomy replaced with melatonin) had an 18F-FDG PET performed at room temperature and after acute cold exposure. The ratio of increased BAT activity after cold exposure/room temperature was called “acute thermogenic capacity” (ATC) We also measured UCP-1 mRNA expression to correlate with the 18F-FDG PET results.

Results

Pinealectomy led to reduced acute thermogenic capacity, compared with the other groups, as well as reduced UCP1 mRNA expression.

Conclusion

Melatonin deficiency impairs BAT response when exposed to acute cold exposure. These results can lead to future studies of the influence of melatonin on BAT, in animals and humans, without needing an invasive evaluation of BAT.

Background

Melatonin is a pineal hormone, produced at night, which has a critical role in the synchronization of circadian rhythms, with known metabolic effects in many animal species [1, 2]. One of its metabolic effects in rodents is a reduction in body weight with a minimal decrease in food intake, suggesting an action on energy expenditure, which possibly relates to activation of brown adipose tissue (BAT) [1,2,3,4,5]. Indeed, many experimental models have shown the role of melatonin on BAT recruitment [3, 6].

BAT is a thermogenic tissue, whose primary function is thermoregulation via non-shivering thermogenesis [7]. Thermogenesis occurs due to a unique and specific enzyme called uncoupling protein-1 (UCP-1), which uncouples ATP energy production in the mitochondria, generating heat [8]. Brown adipose tissue is activated by sympathetic noradrenergic stimuli, and cold is the most important physiological stimulus known [7, 8].

Recently, BAT research has increased after positron emission tomography with 2-deoxy-2-[fluorine-18] fluoro-d-glucose (18F-FDG PET) has shown that humans still possess active BAT, especially after cold exposure [9, 10]. In this context, a lack of BAT activation could have a potential role in weight gain in humans. Therefore, targeting BAT activation could be promising for the treatment of obesity and/or type 2 diabetes [11].

Many compounds have been studied to determine the ability of BAT recruitment and activation, including melatonin [12, 13]. However, in the literature, several melatonin studies conducted in animals measured BAT mass, in order to analyze BAT recruitment and activation, and some of them focused on BAT thermogenesis, measured by calorimetry or cytochrome activity [3], yet none of them used 18F-FDG PET, which is the gold standard for BAT measurement in humans. More recently, some studies have evaluated a possible increase in BAT and in thermoregulatory responses, using infrared thermography [5, 14, 15].

It is worth highlighting that an increase in BAT mass (recruitment) does not necessarily lead to an increased thermogenic response (activation), if there is no physiological need for heat production [7, 8, 16]. In this regard, an increase in BAT mass or UCP-1 expression would not necessarily mean an increase in BAT uptake in 18F-FDG PET [16, 17]. Further concerning this point, different protocols of cold exposure or other adrenergic stimuli could lead to different patterns of BAT uptake by 18F-FDG PET that do not necessarily reflect the total BAT mass of an individual [16].

As 18F-FDG PET is the gold-standard method for the detection of BAT in humans [18], it would be relevant to use this methodology in experimental studies to understand the role of melatonin deficiency and its supplementation on BAT thermogenic responses. This would be important, not only for melatonin, but also for any other compound that could potentially increase BAT mass (since an increase in BAT mass in humans, by any compound, if not increase thermogenesis as well, could only be detected by tissue biopsy and would probably have minimal therapeutic implications).

In the present study, we ought to determine if melatonin deficiency in experimental models of pinealectomized Wistar rats decreases BAT activation, evaluated by Positron emission tomography-computed tomography (PET-CT), at room temperature and after cold exposure, and if melatonin replacement could revert these changes.

Method

Animals and groups

Young male Wistar rats (3 months old) were maintained under a 12-h light/12-h dark cycle, 23 ± 2 °C at the animal facility room of the Neurobiology Lab in the Department of Physiology and Biophysics at the University of São Paulo. All the experimental procedures followed the animal welfare guides within the protocols approved by the Institute of Biomedical Sciences Ethics Committee of the University of São Paulo, under number 30460114.5.3001.5467.

For the PET-CT analysis, the animals were assigned to three groups: healthy animals with an intact pineal gland (C, n = 6); pinealectomized (PINX) animals (P, n = 7); and PINX rats being treated with melatonin (PM, n = 6) from the first day of surgery. A pinealectomy was performed 1 month before the experiment (animals were 2-months old), as previously described [19], and melatonin (1.0 mg/kg of body weight) (Sigma‐Aldrich, St. Louis, MO, USA) was added to their drinking water, exclusively during the dark phase. The concentration in the drinking water solution was corrected daily, using the ingested volume from the previous night. This melatonin protocol was done to mimic physiological levels of melatonin and have already been used in several of our group’s experiments (peak melatonin plasmatic level of 150 pg/ml) [5, 6, 20].

For the UCP1 mRNA expression, we used a larger number of male Wistar rats (15C, 10 P, and 12PM) that, despite not being the same animals that performed the PET-CT analysis, received the exact same protocol of PINX and melatonin supplementation.

Positron emission tomography-computed tomography (PET-CT)

Briefly a small animal imaging Positron emission tomography coupled to a computerized tomography machine was used to follow 2-deoxy-2-[fluorine-18]fluoro-d-glucose physiological uptake in Rats (Additional file 1: Figure S1). Basal imaging (pre-thermogenic stimuli) and 2-days image (post-thermogenic stimuli) were performed using 18F-FDG PET/CT to determine the 18F-FDG uptake images were performed twice, with an interval of 2 days, in both room temperature (23 ± 2 °C) and after an acute cold challenge. During the acute cold challenge, rats were exposed to the environmental temperature of 4 ± 2 °C for 4 h, and immediately afterward, they were scanned using 18F-FDG PET/CT. Our freezing protocol was performed according to the literature available at that moment [21]. The images were performed around ZT 6 (6 h after lights on) to preserve the BAT peak activity in rats as described before [22].

The animals received i.v. 2.474 mCi (91.54 MBq) of 18F-FDG and images were obtained by small imaging PET/CT (Triumph II trimodality System, Gamma Medica/Trifoil imaging), with a field of view (FOV) of 80 mm, matrix 240 × 240. Images were then co-registered with CT for anatomic correlation and analyzed by at least 2 nuclear medicine specialists, using a manually drawed region of interest (ROI) in the interscapular area. The ROI was used to evaluate the interscapular maximal Standard Value Uptake (Max SUV). We analyzed data from both experiments separately as well as the ratio of individual SUV increase (maximal SUV after a cold challenge/maximal SUV in room temperature),which was interpreted as an “acute thermogenic activity of BAT.” The BAT acute thermogenic capacity was measured in each animal individually and the mean results of each group was then compared. The schematic representation of the intervention is illustrated in Fig. 1.

Fig. 1
figure1

Schematic representation of the experimental imaging procedure

UCP-1 mRNA expression

Different male Wistar rats, that received the same protocol of those who performed the imaging technique were euthanized at ZT18 (6 h after lights off) and interscapular brown adipose tissue was collected for UCP-1 mRNA expression analysis. BAT was maintained in dry ice and homogenized in 1 ml of Trizol Reagent (Invitrogen, Carlsbad, CA, USA) for total RNA extraction according to the manufacturer’s instructions. Samples were then treated with DNase (Turbo DNA-free™, Ambion, Austin, TX, USA) and total RNA was quantified at 260 nm using a spectrophotometer, with acceptable 260/280 ratios of 1.8 to 2.0 (NanoDrop 2000, Thermo Scientific, USA). 1ug of total RNA was reverse-transcribed for cDNA synthesis using a mix containing Superscript III reverse transcriptase (200U, Invitrogen, Carlsbad, CA, USA), DTT (10 nM), dNTP (10 mM each) and random primers (150 ng) in a final reaction volume of 20μL. Real time PCR reactions containing 5ug cDNA, ultrapure water, SyBr Green mix (ThermoFisher Scientific, Waltham, MA, USA) and specificintron-spanning primers were performed using 7500 real time PCR system (ThermoFisher Scientific, Waltham, MA, USA) (Table S1, supplementary appendix). and the following cycling parameters: 95 °C for 10 min followed by 40 cycles of 95 °C for 15 s, annealing at 60 °C for 30 s and extension at 72 °C for 30 s. The studied genes presented similar amplification efficiency (E) and the dissociation curves presented only one peak, with the respective single Tm (data not shown). Relative gene expression was calculated by the 2-DCt method [23] using the geometric mean of the housekeeping genes, that presented no alteration among groups, as the normalization factor.

Statistical analysis

The number of animals for each experimental group was calculated by the equation n = 1+[2C(s/d)2] where “s” is the standard deviation, “d” is the difference to be detected and C is a constant calculated from C = (zα + zβ)2. By considering 90% as a power test, p value as 0.05 we will have “C” value is 10.51. Considering s = 0.2 and d = 0.5 we rewrite the equation with the numbers, and we have n = 1 + [2 * 10.51 * (0.2/0.5)2]; e.g. n = 4.36. We also increased the “n” value in 25% whenever it was possible to diminish sample losses due to surgical and experimental procedures during the follow-up.18F-FDG PET data were analyzed by ANOVA, using the software Prism (GraphPad Software, La Jolla California USA).

Results

The cold challenge experiment was useful and increased BAT Max SUV in all three animal models with statistical significance (Fig. 1, Additional file 1). In the PET-CT test performed at room temperature, there were no significant differences between the groups. Surprisingly, though, there was an absolute increase in Max SUV in the P group (Fig. 2a and Table 1).

Fig. 2
figure2

A Maximal SUV at room temperature, ANOVA test C: controls, PM: PINX Melatonin, P: PINX p = 0.13. B Maximal SUV after cold challenge, ANOVA C: controls,, PM: PINX Melatonin, P: PINX p = 0.16

Table 1 Maximal SUV (x10 4) and SD in all models

On the contrary, when the cold exposure protocol (which has a higher sensitivity) was analyzed, the pattern was reversed, and the P group had the lowest mean values. However, once again, no statistical significance was observed (Fig. 2b and Table 1).

When the ratio of increase between the after cold challenge was compared with room temperature (what we called “acute thermogenic capacity”—ATC), we found that the P group had a statistically significant reduction in this parameter (Fig. 3 and Table 1), compared with both of the other groups. This suggests, as expected, that melatonin deficiency could impair BAT thermogenic responses (ANOVA P = 0.03), which are restored with melatonin replacement therapy.

Fig. 3
figure3

Maximal SUV increase (Cold challenge/Room temperature), ANOVA C: controls, PM: PINX Melatonin, P: PINX p = 0.0374 *Statistical significant

We analyzed UCP1 mRNA in a different group of animals that received the exact same protocol.

UCP1 mRNA was analyzed after sacrifice in a similar group of animals, in which the protocol conditions of C, P, and PM were identical to the animals that had the PET-CT performed. ANOVA testing revealed a P < 0.001, confirming differences between the three groups, as expected; the P group had a minimal expression of UCP1, compared with C and PM (Fig. 4). The results confirmed that melatonin deficiency reduces UCP-1 gene expression and that exogenous melatonin supplementation can reestablish its expression.

Fig. 4
figure4

UCP1 RNA expression. ANOVA test: p < 0.001 C: controls, PM: PINX Melatonin, P: PINX

Discussion

We aimed to test if melatonin deficiency (due to surgical pinealectomy) decreased BAT activation, and if melatonin replacement could revert this pattern to normal in Wistar rats, using the gold standard for BAT detection in humans—18F-FDG PET.

This is the first investigation, to our knowledge, to study BAT activation by 18F-FDG PET scan before and after melatonin treatment in animals. Despite data of increased BAT mass, UCP1 expression, and thermogenesis after melatonin replacement in many animal models and species already being demonstrated [3, 6, 14, 15], we found it relevant to investigate if 18F-FDG PET was able to detect these differences, facilitating future research in animals and humans, in which indirect measures of BAT are more feasible to be detected than through direct sample tissues. We believe that testing potential BAT activating compounds by performing an 18F-FDG PET in animals could help the translation of animal to human data. If animals increase their BAT SUV response to a specific compound, future studies can be done in humans to evaluate the same compound using the same method of detection.

In both isolated models (room temperature and after cold challenge), there were no differences between the groups, although some trends could be observed, including an unexpected higher maximal SUV in pinealectomized animals at room temperature and, on the contrary, a reduced maximal SUV in the P group after cold exposure. Since no statistical significance was achieved in any of the isolated methods, we prefer not to over interpret the reasons of this discrepancy. We should bear in mind that performing an 18F-FDG PET at room temperature is less sensitive to detecting differences; since the animals are chronically adapted to that temperature and have a small biological need to activate a recruited BAT. Perhaps in 23 °C room temperature chronic exposure, which is not thermoneutral for rats, but clearly not as challenging as an acute 4 °C exposure, other mechanisms of temperature regulation could be enough to maintain the normal thermoregulatory responses of the animal [3]. Therefore, the absence of differences between the groups in this specific model was not unexpected, at first. There has been a lot of discussion about what the ideal temperature is to perform BAT and other metabolic studies in rodents, and this remains an open question [24, 25]. The initial goal of performing the test at room temperature was exactly to observe if different patterns occurred when compared to the cold challenge and to calculate the ATC. A larger n could probably bring us more answers in future studies. As very few studies have analyzed BAT by PET in rats, our sample size calculation was based on a pilot study, and due to interindividual variances in Maximal SUV, we believe a larger sample size could have led us to results that were more conclusive.

However, comparing the actual ratio of BAT Maximal SUV increase, the acute thermogenic capacity (ATC), was also a primary goal, since it reveals if BAT is recruited to rapidly exert its effects on thermogenesis. In this context, the melatonin deficient group had a clearly reduced ATC, as expected. Since the PM and C groups had similar responses, this further confirms the hypothesis that melatonin proficiency is critical for thermoregulation in settings of acute cold challenging.

Indeed, the findings presented here encouraged our group to conduct an already published human study that demonstrated an increase in BAT volume and activity after melatonin replacement in a group of pinealectomized individuals [26]. Interestingly, in this study, some individuals have a reasonably high baseline BAT activity before melatonin replacement; suggesting that even if melatonin is important for thermoregulation, other mechanisms still exist.

The UCP-1 RNA data in the present study was performed as an additional tool to analyze and interpret our image data. Importantly, other published manuscripts, some of them by our own group, have already shown a decrease in UCP-1 RNA and UCP-1 protein expression after pinealectomy and a reversal of this reduction by melatonin replacement in slightly different experimental models [5, 6, 14, 15]. Therefore, regardless that our UCP-1 results are not original, they reinforce and validate the previous results and help in the interpretation of the image data [5, 6, 14, 15].

The observed pattern of UCP-1 expression in our model is in line with 18F-FDG PET results. The groups were statistically different; the P group has the lowest UCP-1 expression, compared with the other two groups, which in some ways could explain the lower ATC.

However, as already pointed out, an increase in UCP-1 RNA does not necessarily mean more heat production, as this recruited tissue can be inactive, if there is no need to increase thermogenesis [3, 16, 17]. Even differences in RNA and protein expression could arise, as post-transcriptional factors may influence protein synthesis. This could explain why the pinealectomized group showed a normal BAT response in 18F-FDG PET at room temperature, even with having lower UCP-1 expression. We did not expect differences in UCP1 expression between the C and PM groups, since our intent was to reproduce, immediately after pinealectomy, in the PM group, the physiological production of melatonin. Nevertheless, clear differences were observed, so the main hypothesis is that the replacement protocol did not exactly mimic melatonin production. As the animals drink water at specific times of the night, they would probably have several small melatonin peaks, instead of the physiological curve of night melatonin production. In addition, since the melatonin solution was only available from the start of the dark period, the duration of its plasmatic profile might reflect the winter type of melatonin secretion in some animals, changing the physiological pattern of BAT recruitment. These different kinetic curves could explain the differences observed in Fig. 4.

Our main focus in this particular study was to evaluate BAT responses in 18F-FDG PET. As many other different studies have demonstrated the physiological role of melatonin in body weight regulation, food intake, energy expenditure, metabolic risk factors, and many other parameters, we did not include these data as they would be redundant. Our group has previously shown that pinealectomy leads to a metabolic syndrome phenotype in rats and melatonin replacement reverts it [1]. Melatonin has been shown to decrease body weight with a minimal decrease in food intake, suggesting an effect in energy expenditure, proposed to be mediated by BAT [2, 3]. For a more comprehensive review of metabolic consequences of melatonin deficiency and the physiological role of melatonin in several animal models, see references [1, 2].

The research presented here aggregate data on the role of melatonin on thermoregulation, but the model has several limitations. Many questions still persist. Is there a role of melatonin in maintaining thermoneutrality in animals at room temperature, or is it only important if the temperature acutely decreases? Would the same results appear if the cold challenge was less intense and had a longer duration, probably a more physiological challenge? Would ATC be a reliable way to detect recruited BAT in vivo, as our study suggests? We believe so, but to detect clear effects of different compounds, we need to compare differences between the room temperature and cold challenge, since many adaptive mechanisms should exist, as thermoneutrality is vital for survival. Performing exams in only one of these conditions could lead to misinterpretations of the role of BAT and possible recruiters on thermogenesis and there is clear evidence that small differences in laboratory temperatures could lead to very different results in different animal models [24, 25, 27,28,29]. For example, if the tests were performed only after the cold challenge, we could conclude that no differences were seen between the groups, despite large differences in UCP-1mRNA expression. This could have led to an interpretation that UCP-1 is expressed but not necessarily translated, or that FDG-PET is not a reliable way to detect differences in BAT activation in animals.

BAT physiology is very complex, and potential compounds aiming to increase BAT can act in recruitment, activation, or both [3, 7, 11, 12]. Experimental models can help us distinguish between the action of potential BAT recruiters, such as melatonin, and the detection of BAT in vivo, by imaging techniques. Different models have the potential to investigate the role of several recruiters in different laboratory conditions, paving the way for human studies with potential compounds capable of activating or recruiting BAT, besides melatonin [11, 30]. Our finding that melatonin seems critical for acute BAT activation, induced by cold and measured by 18F-FDG PET, is novel. It can lead to future imaging studies in both animals and humans that will help understand the physiological role of melatonin, concerning BAT, and if melatonin could be a potential target for increasing melatonin recruitment and activation in humans, with potential therapeutic use in metabolic diseases [26]. In the same way, the finding of reduced melatonin production, leading to reduced BAT thermogenic responses, can help the understanding of increased light-at-night exposure as a potential risk factor for obesity and metabolic diseases, as already suggested [31, 32].

Conclusions

This is the first study, to our knowledge, evaluating BAT responses to melatonin by 18F-FDG PET, which is an important essential for future melatonin and circadian studies, in animals and humans, to evaluate BAT responses through non-invasive techniques.

We demonstrated that pinealectomy impairs BAT acute thermogenic capacity, measured by 18F-FDG PET in Wistar rats, after an acute cold challenge, and that melatonin replacement reverses this impairment, in line with the results obtained by UCP1 RNA expression. However, when the results at room temperature and after the cold challenge were analyzed separately, no significant differences were seen, highlighting the complexity of thermoregulation and the possible limitations of 18F-FDG PET to detect differences in BAT, depending of the temperature conditions.

These results corroborate many experimental models that suggest that melatonin has a critical role in BAT mass and activity. Studying different compounds that potentially increase BAT by an imaging technique considered to be the gold standard in humans could facilitate future studies in our species.

Availability of data and materials

The data and materials are available, if needed.

References

  1. 1.

    Cipolla-Neto J, Amaral FG, Afeche SC, Tan DX, Reiter RJ. Melatonin, energy metabolism, and obesity: a review. J Pineal Res. 2014;56:371–81.

    CAS  Article  Google Scholar 

  2. 2.

    Cipolla-Neto J, Amaral FGD. Melatonin as a hormone: new physiological and clinical insights. Endocr Rev. 2018;39:990–1028.

    Article  Google Scholar 

  3. 3.

    Tan DX, Manchester LC, Fuentes-Broto L, Paredes SD, Reiter RJ. Significance and application of melatonin in the regulation of brown adipose tissue metabolism: relation to human obesity. Obes Rev. 2011;12:167–1884.

    CAS  Article  Google Scholar 

  4. 4.

    Wolden-Hanson T, Mitton DR, McCants RL, et al. Daily melatonin administration to middle-aged male rats suppresses body weight, intraabdominal adiposity, and plasma leptin and insulin independent of food intake and total body fat. Endocrinology. 2000;141:487–97.

    CAS  Article  Google Scholar 

  5. 5.

    Buonfiglio D, Parthimos R, Dantas R, et al. Melatonin absence leads to long-term leptin resistance and overweight in rats. Front Endocrinol (Lausanne). 2018;9:122.

    Article  Google Scholar 

  6. 6.

    De Souza CAP, Gallo CC, de Camargo LS, et al. Melatonin multiple effects on brown adipose tissue molecular machinery. J Pineal Res. 2019;66(2):e12549.

    Article  Google Scholar 

  7. 7.

    Halpern B, Mancini MC, Halpern A. Brown adipose tissue: what have we learned since its recent identification in human adults. Arq Bras Endocrinol Metabol. 2014;58:889–99.

    Article  Google Scholar 

  8. 8.

    Cannon B, Nedergaard J. Brown adipose tissue: function and physiological significance. Physiol Rev. 2004;84(1):277–359.

    CAS  Article  Google Scholar 

  9. 9.

    van Marken Lichtenbelt WD, Vanhommerig JW, Smulders NM, et al. Cold-activated brown adipose tissue in healthy men. N Engl J Med. 2009;360:1500–8.

    Article  Google Scholar 

  10. 10.

    Nedergaard J, Bengtsson T, Cannon B. Unexpected evidence for active brown adipose tissue in adult humans. Am J Physiol Endocrinol Metab. 2007;293:E444–52.

    CAS  Article  Google Scholar 

  11. 11.

    Loh RKC, Kingwell BA, Carey LA. Human brown adipose tissue as a target for obesity management; beyond cold-induced thermogenesis. Obes Rev. 2017;18(11):1227–42.

    CAS  Article  Google Scholar 

  12. 12.

    Broeders E, Bouvy ND, van Marken Lichtenbelt WD. Endogenous ways to stimulate brown adipose tissue in humans. Ann Med. 2015;47:123–32.

    CAS  Article  Google Scholar 

  13. 13.

    Mukherjee J, Baranwal A, Schade KN. Classification of therapeutic and experimental drugs for brown adipose tissue activation: potential treatment strategies for diabetes and obesity. Curr Diabetes Rev. 2016;12(4):414–28.

    CAS  Article  Google Scholar 

  14. 14.

    Jiménez-Aranda A, Fernández-Vázquez G, Campos D, Tassi M, Velasco-Perez L, Tan DX, Reiter RJ, Agil A. Melatonin induces browning of inguinal white adipose tissue in Zucker diabetic fatty rats. J Pineal Res. 2013;55(4):416–23.

    PubMed  Google Scholar 

  15. 15.

    Fernández-Vázquez G, Reiter RJ, Agil A. Melatonin increases brown adipose tissue mass and function in Zücker diabetic fatty rats: implications for obesity control. J Pineal Res. 2018;64(4):312–472.

    Article  Google Scholar 

  16. 16.

    Nedergaard J, Cannon B. UCP1 mRNA does not produce heat. Biochim et Biophys Acta. 2013;1831:943–9.

    CAS  Article  Google Scholar 

  17. 17.

    Nedergaard J, Cannon B. The browning of white adipose tissue: some burning issues. Cell Metab. 2014;20(3):396–407.

    CAS  Article  Google Scholar 

  18. 18.

    Chen KY, Cypess AM, Laughlin MR, Haft CR, Hu HH, Bredella MA, Enerbäck S, Kinahan PE, Lichtenbelt WV, Lin FI, Sunderland JJ, Virtanen KA, Wahl RL. Brown Adipose Reporting Criteria in Imaging STudies (BARCIST 1.0): recommendations for standardized FDGPET/CT experiments in humans. Cell Metab. 2016;24(2):210–22.

    CAS  Article  Google Scholar 

  19. 19.

    Hoffman RA, Reiter RJ. Rapid pinealectomy in hamsters and other small rodents. Anat Rec. 1965;153(1):19–21.

    CAS  Article  Google Scholar 

  20. 20.

    Mendes C, Lopes AMS, Amaral FG, et al. Adaptations of the aging animal to exercise: role of daily supplementation with melatonin. J Pineal Res. 2013;55:229–39.

    CAS  Article  Google Scholar 

  21. 21.

    Baba S, Jacene HA, Engles JM, Honda H, Wahl RL. CT Hounsfield units of brown adipose tissue increase with activation: preclinical and clinical studies. J Nucl Med. 2010;51(2):246–50.

    Article  Google Scholar 

  22. 22.

    van der Veen DR, Shao J, Chapman S, Leevy WM, Duffield GE. A diurnal rhythm in glucose uptake in brown adipose tissue revealed by in vivo PET-FDG imaging. Obesity (Silver Spring). 2012;20(7):1527–9.

    Article  Google Scholar 

  23. 23.

    Vandesompele J, De Preter K, Pattyn F, et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 2002;3(7):RESEARCH0034.

    Article  Google Scholar 

  24. 24.

    Keijer J, Li M, Speakman JR. What is the best housing temperature to translate mouse experiments to humans? Mol Metab. 2019;25:168–76.

    CAS  Article  Google Scholar 

  25. 25.

    Skop V, Guo J, Liu N, et al. Mouse thermoregulation: introducing the concept of the thermoneutral point. Cell Rep. 2020;31(2):107501.

    CAS  Article  Google Scholar 

  26. 26.

    Halpern B, Mancini M, Bueno C, et al. Melatonin increases brown adipose tissue volume and activity in melatonin deficient patients: a proof-of-concept study. Diabetes. 2019;68:947–52.

    CAS  Article  Google Scholar 

  27. 27.

    Raun SH, Henriquez-Olguín C, Karavaeva I, et al. Housing temperature influences exercise training adaptations in mice. Nat Commun. 2020;11(1):1560.

    CAS  Article  Google Scholar 

  28. 28.

    Cannon B, Nedergaard J. Nonshivering thermogenesis and its adequate measurement in metabolic studies. J Exp Biol. 2011;214:242e253.

    Article  Google Scholar 

  29. 29.

    Kingma BR, Frijns AJ, Schellen L, van Marken Lichtenbelt WD. Beyond the classic thermoneutral zone: including thermal comfort. Temperature (Austin). 2014;1:142e149.

    Google Scholar 

  30. 30.

    Bonet ML, Oliver P, Palou A. Pharmacological and nutritional agents promoting browning of white adipose tissue. Biochim Biophys Acta. 2013;1831(5):969–85.

    CAS  Article  Google Scholar 

  31. 31.

    Nelson RJ, Chbeir S. Dark matters: effects of light at night on metabolism. Proc Nutr Soc. 2018;77(3):223–9.

    Article  Google Scholar 

  32. 32.

    Rybnikova NA, Haim A, Portnov BA. Does artificial light-at-night exposure contribute to the worldwide obesity pandemic? Int J Obes. 2016;40:815–23.

    CAS  Article  Google Scholar 

Download references

Acknowledgements

None.

Funding

Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP) (Grant number 86/2016)—Thematic Project number 2014/50457-0.

Author information

Affiliations

Authors

Contributions

BH, MCM, and JCN designed the experiments. BH conducted all steps of research, with the help of the other authors. BH, MCM, CMLM, MTS, CAB, and JCN analyzed data. BH wrote the manuscript. MCM, MTS, CMLM, FGA, and JCN reviewed the manuscript and gave opinions and ideas. CM and FGA performed the UCP-1 RNA expression data. CMLM was responsible for the FDG-PET exams in animals. SP, CMLM, MTS, and CAB analyzed BAT in the FDG-PET exams and interpreted them. BH, CMLM, MCM, and JCN performed statistical analysis of all data. JCN is responsible for the Thematic Project, in which this trial belongs and received funding. Dr. Jose Cipolla Neto is the guarantor of this work and, as such, he had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Bruno Halpern.

Ethics declarations

Ethics approval and consent to participate

The project has been approved by the Ethics Committee of the Institute of Biomedical Sciences, University of São Paulo, under the number ICB-USP 30460114.5.3001.5467, and registered in Plataforma Brasil.

Consent for publication

All authors consent to its publication.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Additional file 1: Table S1.

Primers used for RT-PCR for UCP-1 expression. Figure S1. Maximal SUV (x104) in all experimental groups in room temperature and after cold exposure.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Halpern, B., Mancini, M.C., Mendes, C. et al. Melatonin deficiency decreases brown adipose tissue acute thermogenic capacity of in rats measured by 18F-FDG PET. Diabetol Metab Syndr 12, 82 (2020). https://doi.org/10.1186/s13098-020-00589-1

Download citation

Keywords

  • Brown adipose tissue
  • Melatonin
  • Obesity
  • Circadian rhythms
  • FDG-PET
  • Thermogenesis
  • UCP-1